Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triple fixed-dose combination versus dual fixed-dose combination for blood pressure control
RBR-5p9w6vzPhase 4Recruiting
- Sponsor
- Barroso e Sebba
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of olmesartan, hydrochlorothiazide and amlodipine in hypertension (HTN) (2 arms), sponsored by Barroso e Sebba. Started Aug 2024; status: recruiting.
02
Drugs
olmesartanhydrochlorothiazideamlodipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on RBR-5p9w6vz.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-5p9w6vz.